Literature DB >> 28120838

Psychosocial effects in parents and children 12 years after newborn genetic screening for type 1 diabetes.

Nicola J Kerruish1, Dione M Healey2, Andrew R Gray3.   

Abstract

Little is known about the psychosocial consequences of testing newborns for genetic susceptibility to multifactorial diseases. This study reports quantitative psychosocial evaluations of parents and children 12 years after screening for type 1 diabetes (T1D). Two parent-child cohorts participated: children at increased genetic risk of T1D and children at low genetic risk. T1D risk status was determined at birth as part of a prospective study investigating potential environmental triggers of autoimmunity. Parent measures included ratings of children's emotional, behavioural and social functioning (Child Behaviour Checklist) and parenting style (Alabama Parenting Questionnaire). Child self-concept was assessed using the self-description questionnaire (SDQ1). Statistical analyses were conducted to test for differences between the groups. Twelve years after testing there was no evidence that knowledge of a child's increased genetic risk of T1D adversely affected parental ratings of their child's emotional, behavioural or social functioning, or impacted upon parenting style. There was no adverse effect upon the child's assessment of their self-concept. This study provides important preliminary data concerning longer-term psychosocial effects of incorporating tests for genetic risk of complex disorders into NBS panels. While it is reassuring that no significant adverse effects have been detected, more data will be required to adequately inform policy.

Entities:  

Mesh:

Year:  2017        PMID: 28120838      PMCID: PMC5386412          DOI: 10.1038/ejhg.2016.190

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  24 in total

Review 1.  Type 1 diabetes: recent developments.

Authors:  Devasenan Devendra; Edwin Liu; George S Eisenbarth
Journal:  BMJ       Date:  2004-03-27

2.  Parents' experiences of newborn screening for genetic susceptibility to type 1 diabetes.

Authors:  Nikki J Kerruish
Journal:  J Med Ethics       Date:  2011-01-25       Impact factor: 2.903

3.  Prospective assessment in newborns of diabetes autoimmunity (PANDA): maternal understanding of infant diabetes risk.

Authors:  Stacy K Carmichael; Suzanne Bennett Johnson; Amy Baughcum; Kerri North; Diane Hopkins; Margaret G Dukes; Jin-Xiong She; Desmond A Schatz
Journal:  Genet Med       Date:  2003 Mar-Apr       Impact factor: 8.822

4.  Family communication between children and their parents about inherited genetic conditions: a meta-synthesis of the research.

Authors:  Alison Metcalfe; Jane Coad; Gill M Plumridge; Paramjit Gill; Peter Farndon
Journal:  Eur J Hum Genet       Date:  2008-04-23       Impact factor: 4.246

5.  Do the parent-child relationship and parenting behaviors differ between families with a child with and without chronic illness? A meta-analysis.

Authors:  Martin Pinquart
Journal:  J Pediatr Psychol       Date:  2013-05-09

6.  Maternal psychological reaction to newborn genetic screening for type 1 diabetes.

Authors:  Nicola J Kerruish; Priscilla L Campbell-Stokes; Andrew Gray; Tony R Merriman; Stephen P Robertson; Barry J Taylor
Journal:  Pediatrics       Date:  2007-07-03       Impact factor: 7.124

7.  The ability of CBCL DSM-oriented scales to predict DSM-IV diagnoses in a referred sample of children and adolescents.

Authors:  Monica Bellina; Paolo Brambilla; Marco Garzitto; Gioia A L Negri; Massimo Molteni; Maria Nobile
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-11-09       Impact factor: 4.785

Review 8.  A systematic review of perceived risks, psychological and behavioral impacts of genetic testing.

Authors:  Jodi T Heshka; Crystal Palleschi; Heather Howley; Brenda Wilson; Philip S Wells
Journal:  Genet Med       Date:  2008-01       Impact factor: 8.822

9.  The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants.

Authors:  William A Hagopian; Henry Erlich; Ake Lernmark; Marian Rewers; Anette G Ziegler; Olli Simell; Beena Akolkar; Robert Vogt; Alan Blair; Jorma Ilonen; Jeffrey Krischer; JinXiong She
Journal:  Pediatr Diabetes       Date:  2011-05-12       Impact factor: 3.409

10.  Whole-genome sequencing in newborn screening? A statement on the continued importance of targeted approaches in newborn screening programmes.

Authors:  Heidi Carmen Howard; Bartha Maria Knoppers; Martina C Cornel; Ellen Wright Clayton; Karine Sénécal; Pascal Borry
Journal:  Eur J Hum Genet       Date:  2015-01-28       Impact factor: 4.246

View more
  1 in total

1.  Effect of newborn screening for critical CHD on healthcare utilisation.

Authors:  Rie Sakai-Bizmark; Hiraku Kumamaru; Eliza J Webber; Dennys Estevez; Laurie A Mena; Emily H Marr; Ruey-Kang R Chang
Journal:  Cardiol Young       Date:  2020-07-02       Impact factor: 1.093

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.